- Home
- PFBC vs MLTX Comparison
PFBC vs MLTX Comparison
Compare PFBC & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PFBC | MLTX |
|---|---|---|
| Founded | 1991 | 2021 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | PFBC | MLTX |
|---|---|---|
| Price | $88.71 | $17.88 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 10 |
| Target Price | ★ $102.67 | $25.70 |
| AVG Volume (30 Days) | 67.6K | ★ 1.1M |
| Earning Date | 01-01-0001 | 06-01-2026 |
| Dividend Yield | ★ 3.56% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.94 | N/A |
| Revenue Next Year | $8.31 | N/A |
| P/E Ratio | $8.85 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $73.08 | $5.95 |
| 52 Week High | $103.05 | $62.75 |
Technical Indicators
Market Signals| Indicator | PFBC | MLTX |
|---|---|---|
| Relative Strength Index (RSI) | 43.77 | 58.83 |
| Support Level | $80.74 | $14.84 |
| Resistance Level | $94.25 | $19.15 |
| Average True Range (ATR) | 2.53 | 1.02 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 40.43 | 58.76 |
Price Performance
Historical ComparisonAbout PFBC Preferred Bank
Preferred Bank is a commercial bank located in California. Its products and services are divided into Personal Banking, Business Banking, and Commercial Banking which includes Checking accounts, Savings accounts, CDs, Loans and Credit, Electronic banking, and Treasury Management. It provides personalized deposit services, real estate finance, commercial loans, and trade finance credit facilities to small and mid-sized businesses and their owners, entrepreneurs, real estate developers and investors, professionals, and high-net-worth individuals. The bank generates a majority of its revenue from Southern and Northern California and Flushing.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.